Company News

  • Snibe received CE List A Certificate for HBV Detection

    Shenzhen, China, 26 May 2022-- Snibe has received the CE List A Certificate for 5 MAGLUMI® CLIA immunoassays of Hepatitis B virus (HBV) detection, covering Anti-HBc IgM, Anti-HBs, HBeAg, Anti-HBe, and anti-HBC. Up to now, 6 CLIA immunoassays for HBV detection have all obtained CE List A Certificate, besides the MAGLUMI® HBsAg (CLIA) Assay.  

  • Snibe Gets CE Mark for COVID-19 Antigen Self-Testing

    Recently, Snibe receives the CE mark for its RapisafeTM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards.

  • Snibe announced a global strategic cooperation with Thermo Fisher Scientific

    From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.

  • Snibe Assays Pass the IFCC-RELA 2022

    Recently, Snibe has passed the IFCC External Quality Assessment Scheme for Reference Laboratories in Laboratory Medicine (IFCC-RELA), and 9 assays from Snibe reference laboratory achieved excellent results during the assessment, including 25-OH-Vitamin D3, 17-OH Progesterone, AP, ALT, Amylase, AST, CK, GGT and LDH.

  • Snibe Collaborates with PKU SBMS to Launch Multicenter Study of HCC

    Aiming to further explore the clinical application of serological indicators in early screening and diagnosis of HCC, the School of Basic Medical Sciences Peking University (SBMS, PKU) held an online meeting on June 25, 2022, to officially announce the launch of the project: Multicenter Study in Evaluating the Combination of Multiple Indicators in HCC Screening. Snibe is the exclusive industry supporter.

more >>

  • Snibe received CE List A Certificate for HBV Detection

    Shenzhen, China, 26 May 2022-- Snibe has received the CE List A Certificate for 5 MAGLUMI® CLIA immunoassays of Hepatitis B virus (HBV) detection, covering Anti-HBc IgM, Anti-HBs, HBeAg, Anti-HBe, and anti-HBC. Up to now, 6 CLIA immunoassays for HBV detection have all obtained CE List A Certificate, besides the MAGLUMI® HBsAg (CLIA) Assay.  More

  • Snibe Gets CE Mark for COVID-19 Antigen Self-Testing

    Recently, Snibe receives the CE mark for its RapisafeTM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards.More

  • Snibe announced a global strategic cooperation with Thermo Fisher Scientific

    From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.More

  • Snibe Assays Pass the IFCC-RELA 2022

    Recently, Snibe has passed the IFCC External Quality Assessment Scheme for Reference Laboratories in Laboratory Medicine (IFCC-RELA), and 9 assays from Snibe reference laboratory achieved excellent results during the assessment, including 25-OH-Vitamin D3, 17-OH Progesterone, AP, ALT, Amylase, AST, CK, GGT and LDH.More

  • Snibe Collaborates with PKU SBMS to Launch Multicenter Study of HCC

    Aiming to further explore the clinical application of serological indicators in early screening and diagnosis of HCC, the School of Basic Medical Sciences Peking University (SBMS, PKU) held an online meeting on June 25, 2022, to officially announce the launch of the project: Multicenter Study in Evaluating the Combination of Multiple Indicators in HCC Screening. Snibe is the exclusive industry supporter.More

Marketing Activity

  • Snibe Digital PCR System Launches at MEDICA 2022

    MEDICA, known as the leading international trade fair for the medical sector, was held in Dusseldorf, Germany, from November 14th to 17th. Snibe is honored to be part of it and bring its cutting-edge products to the world during MEDICA 2022.

  • Snibe Shines at the WorldLab 2022 in Seoul

    WorldLab Seoul 2022, the 24th International Congress of Clinical Chemistry and Laboratory Medicine is held at Coex, Seoul, Korea on 26-30 June 2022, which presents and discusses the latest advances in clinical laboratory diagnosis together with global attendees.

  • Snibe Shows Great Charms at EuroMedlab 2022 in Munich

    EuroMedlab Munich 2022, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 2000 participants, was held in ICM International Congress Center from April 10 to 14, 2022.

  • Snibe Showcases Total Lab Automation at MEDLAB 2020

    From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.

  • Snibe Shines at Medica 2019

    Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.

more >>

  • Snibe Digital PCR System Launches at MEDICA 2022

    MEDICA, known as the leading international trade fair for the medical sector, was held in Dusseldorf, Germany, from November 14th to 17th. Snibe is honored to be part of it and bring its cutting-edge products to the world during MEDICA 2022.More

  • Snibe Shines at the WorldLab 2022 in Seoul

    WorldLab Seoul 2022, the 24th International Congress of Clinical Chemistry and Laboratory Medicine is held at Coex, Seoul, Korea on 26-30 June 2022, which presents and discusses the latest advances in clinical laboratory diagnosis together with global attendees.More

  • Snibe Shows Great Charms at EuroMedlab 2022 in Munich

    EuroMedlab Munich 2022, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 2000 participants, was held in ICM International Congress Center from April 10 to 14, 2022.More

  • Snibe Showcases Total Lab Automation at MEDLAB 2020

    From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.More

  • Snibe Shines at Medica 2019

    Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.More

Video Center

SATLARS-TCA
SATLARS-TCA, a total laboratory automation solutions combined with high throughput, flexibility and scalability, has been grandly launched by Snibe and Thermo Fisher Scientific. SATLARS-TCA connected with the world's fastest CLIA analyzer MAGLUMI X8 possesses the high-throughput sample pre- treatment capability and large storage volume post-analytical module, which makes it a nice automated solution for global laboratories.

More

More

Overseas Exhibition

Item Conference Title Conference Name Date/Location Appointment
1 Medlab Middle East 2023.02.06-09/Dubai Attend
2 Euromedlab 2023.05.21-25/Roma, Italy Attend
3 AACC 2023.07.23-27/Anaheim, USA Attend
Make an appointment
  • * Appointment Time:
  • * Name:
  • * Country:
  • Position:
  • Company/Hospital:
  • * Email:
  • Phone:

Your Other Intention